DDX39B (BAT1), TNF and IL6 gene polymorphisms and association with clinical outcomes of patients with Plasmodium vivax malaria

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Mendonça, Vitor Rr ^a,b   Souza, Ligia Cl ^a,b   Garcia, Gabriela C ^a   Magalhães, Belisa Ml ^c   Lacerda, Marcus Vg ^c   Andrade, Bruno B ^d   Gonçalves, Marilda S ^a,b   Barral Netto, Manoel ^a,b,e  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Fundacao de Medicina Tropical Dr Heitor Vieira Dourado   (Brazil)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e Instituto Nacional de Ciencia e Tecnologia   (Brazil)

Author keywords

DDX39B (BAT1); Immune response; Malaria; Plasmodium vivax; Single nucleotide polymorphisms

Indexed keywords

DDX39B PROTEIN, HUMAN; DEAD BOX PROTEIN; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ALLELE; ANEMIA; BLOOD; BRAZIL; CHILD; CHROMOSOME 6; COMPARATIVE STUDY; COMPLICATION; DISEASE RESISTANCE; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HAPLOTYPE; HUMAN; HYPERBILIRUBINEMIA; IMMUNOLOGY; INFANT; MALE; MIDDLE AGED; PHYSIOLOGY; PLASMODIUM VIVAX MALARIA; PRESCHOOL CHILD; RESPIRATORY INSUFFICIENCY; RISK; SEIZURES; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALLELES; ANEMIA; BRAZIL; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 6; DEAD-BOX RNA HELICASES; DISEASE RESISTANCE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; HYPERBILIRUBINEMIA; INFANT; INTERLEUKIN-6; MALARIA, VIVAX; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RESPIRATORY INSUFFICIENCY; RISK; SEIZURES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84904526086     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-278     Document Type: Article

References (58)

1. WHO, World Malaria Report 2013 Geneva: World Health Organization 2013
2. Biomarkers for susceptibility to infection and disease severity in human malaria. Andrade BB, Barral-Netto M, Mem Inst Oswaldo Cruz 2011 106 Suppl 70 78
3. Heritability of malaria in Africa. Mackinnon MJ, Mwangi TW, Snow RW, Marsh K, Williams TN, PLoS Med 2005 2 340
4. The host genetic diversity in malaria infection. De Mendonça VRR, Goncalves MS, Barral-Netto M, J Trop Med 2012 2012 940616
5. The central MHC gene, BAT1, may encode a protein that down-regulates cytokine production. Allcock RJ, Williams JH, Price P, Genes Cells 2001 6 487 494 (Pubitemid 32487458)
6. Polymorphisms at positions -22 and -348 in the promoter of the BAT1 gene affect transcription and the binding of nuclear factors. Price P, Wong AM-L, Williamson D, Voon D, Baltic S, Allcock RJN, Boodhoo A, Christiansen FT, Hum Mol Genet 2004 13 967 974 (Pubitemid 38628432)
7. Plasma superoxide dismutase-1 as a surrogate marker of vivax malaria severity. Andrade BB, Reis-Filho A, Souza-Neto SM, Raffaele-Netto I, Camargo LMA, Barral A, Barral-Netto M, PLoS Negl Trop Dis 2010 4 650
8. Alleles -308A and -1031C in the TNF-alpha gene promoter do not increase the risk but associated with circulating levels of TNF-alpha and clinical features of vivax malaria in Indian patients. Sohail M, Kaul A, Bali P, Raziuddin M, Singh MP, Singh OP, Dash AP, Adak T, Mol Immunol 2008 45 1682 1692 (Pubitemid 351227404)
9. Plasma and in vitro levels of cytokines during and after a Plasmodium falciparum malaria attack in Gabon. Aubouy A, Deloron P, Migot-Nabias F, Acta Trop 2002 83 195 203 (Pubitemid 35245506)
10. Expression of interleukin-6 family receptors in NK92 cells is regulated by cytokines and not through direct interaction with Plasmodium falciparum-infected erythrocytes. Böttger E, Grangeiro de Carvalho E, Meese S, Kun JFJ, Esen M, J Interferon Cytokine Res 2013 33 65 71
11. Cytokine balance in human malaria: does Plasmodium vivax elicit more inflammatory responses than Plasmodium falciparum? Gonçalves RM, Scopel KKG, Bastos MS, Ferreira MU, PLoS One 2012 7 44394
12. Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Lyke KE, Burges R, Cissoko Y, Sangare L, Dao M, Diarra I, Kone A, Harley R, Plowe CV, Doumbo OK, Sztein MB, Infect Immun 2004 72 5630 5637 (Pubitemid 39303671)
13. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. Abraham LJ, Kroeger KM, J Leukoc Biol 1999 66 562 566 (Pubitemid 29489880)
14. The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults. Kilpinen S, Hulkkonen J, Wang XY, Hurme M, Eur Cytokine Netw 2001 12 62 68 (Pubitemid 32281191)
15. Interleukin-6 gene -174 g > c and -572 g > c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, Lowe GD, Humphries SE, Arterioscler Thromb Vasc Biol 2001 21 1458 1463 (Pubitemid 34219808)
16. Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon. Andrade BB, Rocha BC, Reis-Filho A, Camargo LMA, Tadei WP, Moreira LA, Barral A, Barral-Netto M, Malar J 2009 8 121
17. Towards a precise test for malaria diagnosis in the Brazilian Amazon: comparison among field microscopy, a rapid diagnostic test, nested PCR, and a computational expert system based on artificial neural networks. Andrade BB, Reis-Filho A, Barros AM, Souza-Neto SM, Nogueira LL, Fukutani KF, Camargo EP, Camargo LMA, Barral A, Duarte A, Barral-Netto M, Malar J 2010 9 117
18. Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. Andrade BB, Reis-Filho A, Souza-Neto SM, Clarêncio J, Camargo LMA, Barral A, Barral-Netto M, Malar J 2010 9 13
19. Heme impairs prostaglandin E2 and TGF-beta production by human mononuclear cells via Cu/Zn superoxide dismutase: insight into the pathogenesis of severe malaria. Andrade BB, Araújo-Santos T, Luz NF, Khouri R, Bozza MT, Camargo LMA, Barral A, Borges VM, Barral-Netto M, J Immunol 2010 185 1196 1204
20. Hepatitis B infection is associated with asymptomatic malaria in the Brazilian Amazon. Andrade BB, Santos CJN, Camargo LM, Souza-Neto SM, Reis-Filho A, Clarêncio J, Mendonça VRR, Luz NF, Camargo EP, Barral A, Silva AAM, Barral-Netto M, PLoS One 2011 6 19841
21. Association between the haptoglobin and heme oxygenase 1 genetic profiles and soluble CD163 in susceptibility to and severity of human malaria. Mendonça VRR, Luz NF, Santos NJG, Borges VM, Gonçalves MS, Andrade BB, Barral-Netto M, Infect Immun 2012 80 1445 1454
22. Metabolic Adaptation to tissue iron overload confers tolerance to malaria. Gozzelino R, Andrade BB, Larsen R, Luz NF, Vanoaica L, Seixas E, Coutinho A, Cardoso S, Rebelo S, Poli M, Barral-Netto M, Darshan D, Kühn LC, Soares MP, Cell Host Microbe 2012 12 693 704
23. Networking the host immune response in Plasmodium vivax malaria. Mendonça VRR, Queiroz ATL, Lopes FM, Andrade BB, Barral-Netto M, Malar J 2013 12 69
24. WHO, Guidelines for the treatment of malaria. Second edition Geneva: World Health Organization 2010
25. BAT1, a putative anti-inflammatory gene, is associated with chronic Chagas cardiomyopathy. Ramasawmy R, Cunha-Neto E, Faé KC, Müller NG, Cavalcanti VL, Drigo SA, Ianni B, Mady C, Kalil J, Goldberg AC, J Infect Dis 2006 193 1394 1399 (Pubitemid 43673387)
26. Role of interleukin-6-174 G/C promoter polymorphism in trace metal levels of autopsy kidney and liver tissues. Yalçn S, Kayaalt Z, Söylemezoǧlu T, Int J Hyg Environ Health 2011 214 219 224
27. Gene-gene synergistic effect on atopic asthma: tumour necrosis factor-alpha-308 and lymphotoxin-alpha-NcoI in Taiwan's children. Wang T-N, Chen W-Y, Wang T-H, Chen C-J, Huang L-Y, Ko Y-C, Clin Exp Allergy 2004 34 184 188 (Pubitemid 38315252)
28. Jaundice in malaria. Anand AC, Puri P, J Gastroenterol Hepatol 2005 20 1322 1332 (Pubitemid 43964535)
29. Lipid peroxidation and antioxidant enzymes activity in Plasmodium vivax malaria patients evolving with cholestatic jaundice. Fabbri C, de Cássia Mascarenhas-Netto R, Lalwani P, Melo GC, Magalhães BML, Alexandre MAA, Lacerda MVG, Lima ES, Malar J 2013 12 315
30. Association of HLA alleles with Plasmodium falciparum severity in Malian children. Lyke KE, Fernández-Viňa MA, Cao K, Hollenbach J, Coulibaly D, Kone AK, Guindo A, Burdett LA, Hartzman RJ, Wahl AR, Hildebrand WH, Doumbo OK, Plowe CV, Sztein MB, Tissue Antigens 2011 77 562 571
31. Linkage of mild malaria to the major histocompatibility complex in families living in Burkina Faso. Flori L, Sawadogo S, Esnault C, Delahaye NF, Fumoux F, Rihet P, Hum Mol Genet 2003 12 375 378 (Pubitemid 36285129)
32. A genetic association study in the Gambia using tagging polymorphisms in the major histocompatibility complex class III region implicates a HLA-B associated transcript 2 polymorphism in severe malaria susceptibility. Diakite M, Clark TG, Auburn S, Campino S, Fry AE, Green A, Morris AP, Richardson A, Jallow M, Sisay-Joof F, Pinder M, Kwiatkowski DP, Rockett KA, Hum Genet 2009 125 105 109
33. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. Day NP, Hien TT, Schollaardt T, Loc PP, Chuong LV, Chau TT, Mai NT, Phu NH, Sinh DX, White NJ, Ho M, J Infect Dis 1999 180 1288 1297 (Pubitemid 30070216)
34. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Kern P, Hemmer CJ, Van Damme J, Gruss HJ, Dietrich M, Am J Med 1989 87 139 143 (Pubitemid 19201633)
35. Cytokine gene haplotypes with a potential effect on susceptibility to malaria in sympatric ethnic groups in Mali. Israelsson E, Maiga B, Kearsley S, Dolo A, Homann MV, Doumbo OK, Troye-Blomberg M, Tornvall P, Berzins K, Infect Genet Evol 2011 11 1608 1615
36. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D, Nature 1994 371 508 510
37. Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations. Clark TG, Diakite M, Auburn S, Campino S, Fry AE, Green A, Richardson A, Small K, Teo YY, Wilson J, Jallow M, Sisay-Joof F, Pinder M, Griffiths MJ, Peshu N, Williams TN, Marsh K, Molyneux ME, Taylor TE, Rockett KA, Kwiatkowski DP, J Infect Dis 2009 199 569 575
38. TNFalpha-308A associated with shorter intervals of Plasmodium falciparum reinfections. Meyer CG, May J, Luty AJ, Lell B, Kremsner PG, Tissue Antigens 2002 59 287 292
39. TNFalpha*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans. Wattavidanage J, Carter R, Perera KL, Munasingha A, Bandara S, McGuinness D, Wickramasinghe AR, Alles HK, Mendis KN, Premawansa S, Clin Exp Immunol 1999 115 350 355 (Pubitemid 29052462)
40. IL1B, IL4R, IL12RB1 and TNF gene polymorphisms are associated with Plasmodium vivax malaria in Brazil. Sortica VA, Cunha MG, Ohnishi MDO, Souza JM, Ribeiro-Dos-Santos AKC, Santos NPC, Callegari-Jacques SM, Santos SEB, Hutz MH, Malar J 2012 11 409
41. Allele-specific repression of lymphotoxin-alpha by activated B cell factor-1. Knight JC, Keating BJ, Kwiatkowski DP, Nat Genet 2004 36 394 399 (Pubitemid 38437263)
42. TNF as a malaria candidate gene: polymorphism-screening and family-based association analysis of mild malaria attack and parasitemia in Burkina Faso. Flori L, Delahaye NF, Iraqi FA, Hernandez-Valladares M, Fumoux F, Rihet P, Genes Immun 2005 6 472 480 (Pubitemid 43090505)
43. Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual's NRTI-SN risk. Cherry CL, Rosenow A, Affandi JS, McArthur JC, Wesselingh SL, Price P, AIDS Res Hum Retroviruses 2008 24 117 123 (Pubitemid 351282105)
44. Ancestral haplotypes carry haplotypic and haplospecific polymorphisms of BAT1: possible relevance to autoimmune disease. Degli-Esposti MA, Leelayuwat C, Dawkins RL, Eur J Immunogenet 1992 19 121 127
45. Association of alleles carried at TNFA -850 and BAT1-22 with Alzheimer's disease. Gnjec A, D'Costa KJ, Laws SM, Hedley R, Balakrishnan K, Taddei K, Martins G, Paton A, Verdile G, Gandy SE, Broe GA, Brooks WS, Bennett H, Piguet O, Price P, Miklossy J, Hallmayer J, McGeer PL, Martins RN, J Neuroinflammation 2008 5 36
46. Association of variants in the BAT1-NFKBIL1-LTA genomic region with protection against myocardial infarction in Europeans. Koch W, Hoppmann P, Michou E, Jung V, Pfeufer A, Mueller JC, Gieger C, Wichmann H-E, Meitinger T, Schömig A, Kastrati A, Hum Mol Genet 2007 16 1821 1827 (Pubitemid 47244530)
47. Autoimmune hepatitis, HLA and extended haplotypes. Oliveira LC, Porta G, Marin MLC, Bittencourt PL, Kalil J, Goldberg AC, Autoimmun Rev 2011 10 189 193
48. BAT1 promoter polymorphism is associated with rheumatoid arthritis susceptibility. Quiñones-Lombraña A, Lopez-Soto A, Ballina-Garcia FJ, Alperi-López M, Queiro-Silva R, Lopez-Vazquez A, Lopez-Larrea C, Gonzalez S, J Rheumatol 2008 35 741 744 (Pubitemid 351747110)
49. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Karunaweera ND, Grau GE, Gamage P, Carter R, Mendis KN, Proc Natl Acad Sci U S A 1992 89 3200 3203
50. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW, J Exp Med 1993 177 557 560 (Pubitemid 23117109)
51. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO, Proc Natl Acad Sci U S A 1990 87 1233 1237
52. In vitro cytokine production by HLA-B8, DR3 positive subjects. Candore G, Cigna D, Gervasi F, Colucci AT, Modica MA, Caruso C, Autoimmunity 1994 18 121 132 (Pubitemid 24289920)
53. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SG, Peña AS, Scand J Immunol 1996 43 456 463 (Pubitemid 26104933)
54. A novel link of HLA locus to the regulation of immunity and infection: NFKBIL1 regulates alternative splicing of human immune-related genes and influenza virus M gene. An J, Nakajima T, Shibata H, Arimura T, Yasunami M, Kimura A, J Autoimmun 2013 47 25 33
55. Tumor necrosis factor SNP haplotypes are associated with iron deficiency anemia in West African children. Atkinson SH, Rockett KA, Morgan G, Bejon PA, Sirugo G, O'Connell MA, Hanchard N, Kwiatkowski DP, Prentice AM, Blood 2008 112 4276 4283
56. HLA-DPB1 and NFKBIL1 may confer the susceptibility to chronic thromboembolic pulmonary hypertension in the absence of deep vein thrombosis. Kominami S, Tanabe N, Ota M, Naruse TK, Katsuyama Y, Nakanishi N, Tomoike H, Sakuma M, Shirato K, Takahashi M, Shibata H, Yasunami M, Chen Z, Kasahara Y, Tatsumi K, Kuriyama T, Kimura A, J Hum Genet 2009 54 108 114
57. NFKBIL1 confers resistance to experimental autoimmune arthritis through the regulation of dendritic cell functions. Chiba T, Matsuzaka Y, Warita T, Sugoh T, Miyashita K, Tajima A, Nakamura M, Inoko H, Sato T, Kimura M, Scand J Immunol 2011 73 478 485
58. Genetic variation on the BAT1-NFKBIL1-LTA region of major histocompatibility complex class III associates with periodontitis. Kallio KAE, Marchesani M, Vlachopoulou E, Mäntylä P, Paju S, Buhlin K, Suominen AL, Contreras J, Knuuttila M, Hernandez M, Huumonen S, Nieminen MS, Perola M, Sinisalo J, Lokki M-L, Pussinen PJ, Infect Immun 2014 82 1939 1948